"Das Luzerner Kantonsspital (LUKS) ist das grösste Zentrumsspital der Schweiz. Es umfasst die Standorte Luzern, Sursee und Wolhusen sowie die Luzerner Höhenklinik Montana. Rund 7'000 Mitarbeitende sorgen rund um die Uhr für das Wohl der Patientinnen und Patienten. Das LUKS verfügt über 870 Akutbetten und versorgt ein Einzugsgebiet mit rund 700'000 Einwohnern. Es behandelt jährlich über 43'000 stationäre Patientinnen und Patienten und zählt über 600'000 ambulante Patientenkontakte. Die Kliniken und Institute des LUKS bieten medizinische Leistungen von höchster Qualität."

During the past decade, Luzerner Kantonsspital conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 17 clinical trials were completed, i.e. on average, 15.5% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 12 clinical trials were completed. i.e. 21.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Luzerner Kantonsspital" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 40 trials, followed by "Luzerner Kantonsspital" with 22 trials sponsored, "University Hospital, Basel, Switzerland" with 12 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 10 trials sponsored and "University Hospital Inselspital, Berne" with 10 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Luzerner Kantonsspital" #1 collaborator was "Luzerner Kantonsspital" with 9 trials as a collaborator, "University Hospital Inselspital, Berne" with 7 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 5 trials as a collaborator, "Hoffmann-La Roche" with 5 trials as a collaborator and "Swiss National Science Foundation" with 4 trials as a collaborator. Other collaborators include 152 different institutions and companies that were collaborators in the rest 134 trials.

According to Clinical.Site data, the most researched conditions in "Luzerner Kantonsspital" are "Breast Cancer" (10 trials), "Coronary Artery Disease" (9 trials), "Prostate Cancer" (7 trials), "Heart Failure" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Luzerner Kantonsspital" in a lesser frequency.

Most popular intervention types in "Luzerner Kantonsspital" are "Drug" (76 trials), "Device" (39 trials), "Other" (22 trials), "Procedure" (17 trials) and "Behavioral" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ibrutinib" (5 trials), "Atezolizumab" (4 trials), "Bevacizumab" (4 trials) and "Venetoclax" (4 trials). Other intervention names were less common.

The vast majority of trials in "Luzerner Kantonsspital" are 160 trials for "All" genders, 15 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 68 active trials in "Luzerner Kantonsspital". 2 are not yet recruiting, 40 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 84 completed trials in Luzerner Kantonsspital, 1 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Luzerner Kantonsspital, 5 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 52 trials that are defined as “Not Applicable".

Luzerner Kantonsspital has several departments that took part in Clinical trials: "Luzerner Kantonsspital; Medizinische Onkologie" - 5 trials, "Kantonsspital Luzern, Department of Cardiology" - 3 trials, "Luzerner Kantonsspital, Hämatologie" - 2 trials